Edition:
United States

AmerisourceBergen Corp (ABC.N)

ABC.N on New York Stock Exchange

92.78USD
27 Jul 2017
Change (% chg)

-- (--)
Prev Close
$92.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
362,812
52-wk High
$97.85
52-wk Low
$68.38

Latest Key Developments (Source: Significant Developments)

U.S. Senator Claire McCaskill opioid investigation expands to include distributors and additional manufacturers‍​
Thursday, 27 Jul 2017 08:30am EDT 

July 27 (Reuters) - Allergan Plc :U.S. Senator Claire McCaskill opioid investigation expands to include distributors and additional manufacturers‍​.U.S. Senator Claire McCaskill - newest requests for documents, information from opioid manufacturers were sent to Mallinckrodt, Endo, Teva, Allergan‍ ​.U.S. Senator Claire McCaskill - request to McKesson, AmerisourceBergen, Cardinal Health Inc focused on their distribution of opioid products.  Full Article

AmerisourceBergen says ‍announced a new organizational structure
Monday, 19 Jun 2017 06:30am EDT 

June 19 (Reuters) - Amerisourcebergen Corp :Says ‍announced a new organizational structure designed to further align organization to its customer needs​.Amerisourcebergen - customer-facing offerings to be aligned under 2 groups.Says co's operations will continue to be comprised of pharmaceutical distribution services reportable segment and other.Says ‍has also formed a new management committee to enable quicker, cross-functional decision-making​.  Full Article

Amerisourcebergen reports Q2 EPS $1.86
Thursday, 4 May 2017 06:30am EDT 

May 4 (Reuters) - Amerisourcebergen Corp :Amerisourcebergen reports second quarter fiscal year 2017 results.Adjusted diluted EPS guidance raised to $5.77 to $5.92 for fiscal year 2017.Q2 adjusted earnings per share $1.77.Continues to expect brand inflation of 7 pct to 9 pct and generic deflation of -7 pct to -9 pct for fiscal year 2017.Sees fy 2017 adjusted earnings per share $5.77 to $5.92.Q2 GAAP earnings per share $1.86.Q2 revenue $37.1 billion versus I/B/E/S view $38.09 billion.Q2 earnings per share view $1.68 -- Thomson Reuters I/B/E/S.Amerisourcebergen corp sees FY 2017 revenue growth in range of 5.5 percent to 6.5 percent, compared to previous assumption of 6.5 percent to 8 percent.Amerisourcebergen corp sees fiscal 2017 brand drug inflation in range of 7 percent to 9 percent.Amerisourcebergen corp sees fiscal 2017 generic drug deflation in range of -7 percent to -9 percent.Amerisourcebergen corp sees fiscal 2017 contributions from new generic launches similar to prior year.FY2017 earnings per share view $5.82, revenue view $156.48 billion -- Thomson Reuters I/B/E/S.  Full Article

Amerisourcebergen reports new 5-year pharmaceutical supply agreement with Express Scripts
Monday, 1 May 2017 06:30am EDT 

May 1 (Reuters) - Amerisourcebergen Corp ::Amerisourcebergen announces new five-year pharmaceutical supply agreement with express scripts.Agreement extends through september 30, 2022.Amerisourcebergen Corp - fiscal year 2016 revenue contribution from that agreement was approximately $23 billion.Amerisourcebergen Corp- amerisourcebergen and express scripts' most recent supply agreement began in oct. 2012 and was set to expire in september 2017.Signed a new five-year agreement to supply pharmaceuticals to express scripts holding company.  Full Article

AmerisourceBergen Q1 adjusted earnings per share $1.36
Tuesday, 31 Jan 2017 06:30am EST 

AmerisourceBergen Corp : AmerisourceBergen reports first quarter fiscal year 2017 results . Q1 adjusted earnings per share $1.36 . Q1 earnings per share view $1.23 -- Thomson Reuters I/B/E/S . Sees fy 2017 adjusted earnings per share $5.72 to $5.92 . Q1 gaap earnings per share $1.11 . Sees fy 2017 revenue up 6.5 to 8 percent . Q1 revenue $38.2 billion versus I/B/E/S view $38.97 billion . AmerisourceBergen Corp sees 2017 adjusted diluted earnings per share to be in range of $5.72 to $5.92, compared to previous range of $5.63 to $5.88 . Fy2017 earnings per share view $5.75, revenue view $157.71 billion -- Thomson Reuters I/B/E/S . AmerisourceBergen corp sees 2017 revenue growth in range of 6.5 percent to 8 percent .Sees FY 2017 adjusted operating income in range of flat to up 4 percent.  Full Article

Moody's says largest US drug distributors face pricing pressure as they court independent pharmacies
Tuesday, 29 Nov 2016 10:26am EST 

Moody's: Moodys: Largest US drug distributors face pricing pressure as they court independent pharmacies .Moody's on largest U.S. drug distributors - "As drug distributors chase independent pharmacy customers, their margins will come under greater pressure".  Full Article

AmerisourceBergen, units entered into sixth amendment, restatement agreement to amend, restate credit agreement, dated as of March 18, 2011
Tuesday, 22 Nov 2016 04:17pm EST 

Amerisourcebergen Corp : AmerisourceBergen says on Nov 18, co, units entered into sixth amendment, restatement agreement to amend, restate credit agreement, dated as of March 18, 2011 .Multi-Currency revolving credit facility was amended to extend maturity date of facility to Nov 18, 2021 - SEC filing.  Full Article

AmerisourceBergen Q3 GAAP earnings per share $1.56
Tuesday, 2 Aug 2016 06:30am EDT 

AmerisourceBergen Corp : AmerisourceBergen reports third quarter fiscal year 2016 results . Q3 revenue $36.9 billion versus I/B/E/S view $36.71 billion . Q3 GAAP earnings per share $1.56 . Q3 adjusted earnings per share $1.37 excluding items . Sees FY 2016 adjusted earnings per share $5.52 to $5.57 . Q3 earnings per share view $1.27 -- Thomson Reuters I/B/E/S . Sees FY 2016 capital expenditures in $400 million range . Sees FY revenue growth of approximately 8 percent . Amerisourcebergen says fy 2017 adjusted earnings per share is expected to grow in range of 4 to 6 percent above midpoint of updated fiscal 2016 guidance . FY 2017 earnings per share view $5.82 -- Thomson Reuters I/B/E/S . AmerisourceBergen says continue to expect gross profit in Q4 to be negatively impacted by headwinds co identified in early May . AmerisourceBergen says continues to expect that headwinds that are impacting fiscal 2016 will continue well into fiscal 2017 .Now expects share repurchases under co's regular programs of about $350 million, as well as special share repurchases to satisfy hedging programs.  Full Article

AmerisourceBergen Corp and publix announce distribution agreement
Thursday, 4 Feb 2016 07:00am EST 

AmerisourceBergen Corp:AmerisourceBergen and publix announce distribution agreement.Long-term agreement encompassing the distribution of branded, generic and over-the-counter health and pharmaceutical products.  Full Article

AmerisourceBergen Corp announces changes to its board of directors
Wednesday, 18 Nov 2015 06:45am EST 

AmerisourceBergen Corp:Says Richard C. Gozon's retirement as Chairman of the Board at the annual meeting of stockholders in March 2016.Says Steven H. Collis, President and Chief Executive Officer, will succeed Mr. Gozon as Chairman of the Board.  Full Article

Cost controls help drug wholesaler AmerisourceBergen's profit beat

AmerisourceBergen Corp's profit beat analysts' estimates as it reined in costs and the drug wholesaler raised the lower end of its earnings forecast for the fiscal year, allaying concerns that declining generic drug prices would hurt the pharma supply chain.